NICE backtracks to approve Janssen’s Stelara in ulcerative colitis
April 28, 2020Manufacturing and Production, Research and Development Janssen, NICE, Stelara, ulcerative colitis
NICE has recommended Janssen’s Stelara (ustekinumab) for the treatment of moderately to severely active ulcerative colitis (UC), a move which …
South Korean researchers start testing pancreatitis drug in COVID-19 patients
April 28, 2020Manufacturing and Production COVID-19, Pancreas, Pancreatitis, coronavirus
The South Korean Ministry of Food and Drug Safety have approved a local trial to evaluate nafamostat’s effectiveness in COVID-19 …
12 British children hospitalised with rare condition linked to COVID-19
April 28, 2020Manufacturing and Production COVID-19, NHS, NHS UK, coronavirus
12 children have fallen ill across the UK with a new and potentially fatal combination of symptoms linked to COVID-19. …
Reinventing the value equation
April 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, feature, real world data, real world evidence, real-world data, real-world evidence
There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper …
Sanofi’s Meningococcal Conjugate Vaccine secures FDA approval in patients aged two and up
April 27, 2020Sales and Marketing FDA, MenQuadfi, Sanofi, US, meningococcal disease, pharma
Sanofi’s MedQuadfi Meningococcal Conjugate Vaccine has scored FDA approval for the prevention of invasive meningococcal disease, becoming the first and …
Italy to relax COVID-19 lockdown in early May
April 27, 2020Sales and Marketing COVID-19, COVID-19 coronavirus, Italy, coronavirus
Italy has outlined its plans to ease the lockdown restrictions that were implemented across the country 7 weeks ago to …
Researchers studying heartburn drug as potential coronavirus treatment
April 27, 2020Sales and Marketing COVID-19, Pepcid, coronavirus, pandemic
Researchers in America have been studying famotidine, the active ingredient in Pepcid, as a potential treatment for COVID-19. Pepcid is …
‘Excess deaths’ in England among the highest in Europe
April 27, 2020Sales and Marketing COVID-19, coronavirus, deaths, pandemic
English excess deaths from the coronavirus are comparable to the worst hit countries in Europe, according to a Sky News …
FDA urges close monitoring of COVID-19 patients treated with hydroxychloroquine
April 27, 2020Sales and Marketing COVID-19, FDA, chloroquine, coronavirus, hydroxychloroquine
The FDA has released a safety communication reiterating the need for doctors to closely monitor COVID-19 patients who are treated …
European Medicines Agency’s review of Picato finds its risks outweigh its benefits
April 24, 2020Business Services, Medical Communications, Sales and Marketing
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the risks from using Picato are too high …
Leading COVID-19 hope remdesivir fails to provide clinical benefit in first randomised trial
April 24, 2020Medical Communications, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage …
Top Ten most popular articles on Pharmafile.com this week
April 24, 2020Medical Communications COVID-19, coronavirus, top 10
Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while …
European countries wary about confronting China over COVID-19 death figures
April 24, 2020Medical Communications COVID-19, China, coronavirus
National security experts in the UK and US believe China is underreporting the true amount of COVID-19 deaths, but European …
Trump widely criticised for suggesting patients could receive injections of disinfectant as COVID-19 cure
April 24, 2020Medical Communications COVID-19, coronavirus
President Donald Trump stunned the medical community by suggesting disinfectant and UV light could be used to treat patients suffering …
Socially disruptive measures will exist in Britain until at least the end of the year
April 23, 2020Business Services Britian COVID-19, COVID-19, coronavirus
England’s Chief Medical Officer Chris Whitty has said that the UK will have to live with some form of socially …
FDA approves Immunomedics’ Trodelvy for metastatic triple-negative breast cancer one month ahead of schedule
April 23, 2020Sales and Marketing Cancer, Immunomedics, Trodelvy, breast cancer, pharma
Immunomedics has scored approval with the FDA for Trodelvy (sacituzumab govitecan-hziy) in the treatment of metastatic triple-negative breast cancer, it …
Cheaper Canadian drug imports continue to be seized by the FDA
April 23, 2020Business Services COVID-19, Canada, FDA, coronavirus, insulin
Seizures of Canadian drugs being sent to American patients have been stepped up by the FDA. This is according to …
Novartis’ Jakavi Phase 3 trial is first of its kind to hit main goal in steroid-refractory acute graft-versus-host disease
April 23, 2020Research and Development Jakavi, Novartis, pharrma
Novartis has revealed impactful new Phase 3 data for its therapy Jakavi (ruxolitinib) in the treatment of patients with steroid-refractory …
BARDA director abruptly leaves post, claims he was ousted over pushback to hydroxychloroquine
April 23, 2020Business Services COVID-19, HHS, coronavirus
Rick Bright has claimed that he has been forced out of his position as the Director of the US Biomedical …
Boehringer’s nintedanib approved in Europe for systemic sclerosis-associated interstitial lung disease
April 22, 2020Research and Development, Sales and Marketing Boehringer Ingelheim, EU, nintedanib, pharma
The European Commission has moved to authorise Boehringer Ingelheim’s nintedanib in Europe for the treatment of systemic sclerosis-associated interstitial lung …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
